|Articles|January 1, 2008
New HPV vaccine attempts to go global
Advertisement
Global News
GlaxoSmithKline is trying to obtain prequalification from the World Health Organization (WHO) for its new human papillomavirus (HPV) vaccine, Cervarix. Cervarix has already been approved in Europe, and is under review in the US.
If WHO grants the prequalification, then United Nations groups like UNICEF can distribute the vaccine to developing nations. Cervarix, similar to Merck's Gardasil, can substantially reduce the risk of cervical cancer, if given to girls before they become sexually active.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Genomic sequencing may transform newborn screening
2
Kathryn M. Stephenson, MD, MA, discusses GLP-1 RA decisions for pediatric obesity
3
AAP calls for system-level changes to improve children’s digital media environments
4
AAP updates guidance on therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy
5